The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to developer ...

Delayed empiric antibiotics in kidney transplant patients with urosepsis are strongly linked to increased mortality and AKI ...

Swiss pharmaceutical firm Roche has advanced its antibiotic candidate, zosurabalpin, into Phase 3 clinical trials, ...

A new Rutgers Health study reveals a surprising twist in the antibiotic resistance story: instead of simply killing bacteria, ...

A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for urinary tract infections, throws Escherichia ...

It's usually prescribed to bring relief for a specific type of infection, but officials now say there's a "microbial ...

Sexual activity can increase the risk of urinary tract infections UTIs especially in women An expert explains why sex may ...

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of Tarivid ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...

Drugmaker Innoviva Specialty Therapeutics announced today that the US Food and Drug Administration (FDA) has accepted its new ...